Skip to content

Incidence and Factors Associated With Double-J Urinary Stent Infection (IJJ)

Incidence and Factors Associated With Double-J Urinary Stent Infection (IJJ)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03869580
Acronym
IJJ
Enrollment
800
Registered
2019-03-11
Start date
2019-04-30
Completion date
2021-12-31
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Double J Stent

Brief summary

The aim of the study was to determine the incidence and factors associated with double-J urinary stent infection.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with a double-J stent placement or change in the hospital

Exclusion criteria

* renal transplants less than one year old

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with urinary tract infection associated with double J stent6 monthsNumber of patients with urinary tract infection associated with double J stent
Number of patients with specific clinical data associated with urinary tract infection associated with double J stent6 monthsClinical data (Age, sex, gender, comorbidities, indication of procedure, duration of double J stent placement) will be compared between patient with urinary tract infection and no urinary tract infection associated with double J stent

Secondary

MeasureTime frameDescription
Number of patients with relapse and/or recurrence after a first urinary tract infection6 monthsNumber of patients with relapse and/or recurrence after a first urinary tract infection

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026